India is watching the world’s first CRISPR-based leishmaniasis (kala-azar) vaccine trials. Developed by Dr. Satoskar, it aims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results